SK bioscience to acquire future equity in U.S. biotech firm Sunflower Therapeutics
SK bioscience Co., a biopharmaceutical arm of South Korea’s SK Group, said Thursday it has agreed to invest US$2 million to acquire future shares in U.S. biotech company Sunflower Therapeutics.
SK bioscience signed a simple agreement for future equit…